XOMA Corporation

NasdaqGM XOMA

XOMA Corporation Price to Book Ratio (P/B) on January 14, 2025: 3.54

XOMA Corporation Price to Book Ratio (P/B) is 3.54 on January 14, 2025, a 62.63% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.

XOMA Corporation 52-week high Price to Book Ratio (P/B) is 4.49 on November 26, 2024, which is 26.84% above the current Price to Book Ratio (P/B).
XOMA Corporation 52-week low Price to Book Ratio (P/B) is 2.10 on January 18, 2024, which is -40.53% below the current Price to Book Ratio (P/B).
XOMA Corporation average Price to Book Ratio (P/B) for the last 52 weeks is 3.22.

Key data

Date	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield	Price to Earnings Ratio (P/E)

NasdaqGM: XOMA

XOMA Corporation

CEO	Mr. Owen P. Hughes Jr.
IPO Date	June 6, 1986
Location	United States
Headquarters	2200 Powell Street
Employees	13
Sector	Health Care
Industries Biotechnology Pharmaceuticals

Description

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Key trends

Past 5 years